CapsCanada Expands K-CAPS®(HPMC Capsules) Manufacturing Capacity for Second Time

$28 Million invested in new 100,000 square foot K-CAPS® facility with additional 50% capsule production increase; nearly 3-times the amount CapsCanada invested in a 2014 HPMC capsule expansion to meet rising global demand for K-CAPS®.

POMPANO BEACH, Fla., Feb. 27, 2018 /PRNewswire/—CapsCanada, a leading provider of capsules for pharmaceutical drugs and dietary supplements, announced today the addition of a new, state-of-the-art, dedicated hydroxypropyl methylcellulose (HPMC) capsule manufacturing facility. With this investment, CapsCanada has now increased capsule output by 50%.

Produced with 100% plant-derived material, CapsCanada's K-CAPS® are ideal for consumers with dietary restrictions prohibiting the consumption of animal byproduct and are suitable for a wide range of formulations.

"The new factory was built because we saw worldwide acceptance of K-CAPS® as the preferred HPMC based capsule. Compared to other HPMC capsules, K-CAPS® have exceptional aesthetics and perform better on automatic capsule filling machines; directly translating into reduced raw material loss and downtime for our customers." According to Jonathan Gilinski, Executive Director.

"We are delighted by the mass adoption of our K-CAPS® technology and the value it provides to our customers," Gilinski added. CapsCanada is the original innovator and leading manufacturer of HPMC capsules for a variety of applications, including those that are liquid, hygroscopic or otherwise sensitive to moisture. The company previously made a $10 million expansion of their Windsor, Ontario site in 2014, experiencing growing global demand for its products. K-CAPS® are already sold in more than 60 countries worldwide.



Contact:

Ursula Kennedy 
CapsCanada 
+1 (954) 979-6440 
info@capscanada.com

SOURCE CapsCanada

 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

CapsCanada

Founded in 1984, CapsCanada is a leading provider of empty capsules for pharmaceutical drugs and dietary supplements. CapsCanada caters to the most prestigious pharmaceutical manufacturers around the world.